Using text messages to help prevent suicide in young adults
mHealth for suicide prevention: Design, development, and feasibility of a scalable SMS-based safety planning intervention
This study is testing a friendly text message program designed to help young adults aged 18-24 who are struggling with thoughts of suicide, making it easier for them to get support whenever they need it, right from their phones.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10862825 on NIH RePORTER |
What this research studies
This research focuses on developing a text message-based intervention aimed at preventing suicide among young adults aged 18-24, who are experiencing increasing rates of suicidal thoughts and behaviors. The approach leverages digital technology to provide immediate, private support that fits into the daily lives of individuals, addressing barriers to traditional mental health care. By utilizing user-centered design methods, the project aims to create a scalable solution that can effectively engage young adults in managing their mental health. The intervention will be tested for feasibility and effectiveness in reaching those who may not seek conventional treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are young adults aged 18-24 who are experiencing suicidal thoughts or behaviors.
Not a fit: Patients outside the age range of 18-24 or those who are not experiencing suicidal thoughts may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide young adults with accessible and immediate support for managing suicidal thoughts and behaviors.
How similar studies have performed: Previous research has shown promise in using digital interventions for mental health, indicating potential success for this approach.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Meyerhoff, Jonah — Northwestern University at Chicago
- Study coordinator: Meyerhoff, Jonah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.